» Articles » PMID: 2391366

Invariant Chain Trimers Are Sequestered in the Rough Endoplasmic Reticulum in the Absence of Association with HLA Class II Antigens

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 1990 Sep 1
PMID 2391366
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

HLA class II antigens are heterodimeric cell surface glycoproteins that interact with antigenic peptides to form complexes recognizable by CD4-positive T cells. During their biosynthesis, class II antigens are retained in a post-Golgi compartment in association with the invariant chain, which dissociates before class II cell surface expression. To address whether the invariant chain mediates this post-Golgi retention, its transport and assembly were examined in cells that do not express HLA class II antigens. Pulse-chase analysis and endoglycosidase digestions showed that very little invariant chain proceeded as far as the trans-Golgi in class II-negative cell lines. Immunofluorescence studies suggested that in these cells the invariant chain is sequestered in the RER. Gel filtration and cross-linking data showed that RER-localized invariant chain is present as trimers or aggregated trimers. Multimerization is mediated by lumenal interactions; a proteolytic fragment of the invariant chain corresponding to the lumenal domain remained trimeric as determined by cross-linking analysis. Similar transport and structural characteristics were observed for a pool of excess invariant chain in class II-positive cells, suggesting that an excess of invariant chain in the ER may be important for class II antigen function. These results have important implications for the transport of cellular proteins in general and for the role of the invariant chain in class II antigen biosynthesis.

Citing Articles

CD74 is a functional MIF receptor on activated CD4 T cells.

Zhang L, Woltering I, Holzner M, Brandhofer M, Schaefer C, Bushati G Cell Mol Life Sci. 2024; 81(1):296.

PMID: 38992165 PMC: 11335222. DOI: 10.1007/s00018-024-05338-5.


Analysis of CD74 Occurrence in Oncogenic Fusion Proteins.

Vargas J, Pantouris G Int J Mol Sci. 2023; 24(21).

PMID: 37958963 PMC: 10650716. DOI: 10.3390/ijms242115981.


GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition.

Hathaway-Schrader J, Norton D, Hastings K, Doonan B, Fritz S, Bethard J Int J Mol Sci. 2022; 23(3).

PMID: 35162988 PMC: 8835040. DOI: 10.3390/ijms23031066.


The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers.

Cloutier M, Fortin J, Thibodeau J BMC Immunol. 2021; 22(1):56.

PMID: 34384367 PMC: 8362237. DOI: 10.1186/s12865-021-00444-6.


Immune stimulation of rainbow trout reveals divergent regulation of MH class II-associated invariant chain isoforms.

Semple S, Heath G, Christie D, Braunstein M, Kales S, Dixon B Immunogenetics. 2019; 71(5-6):407-420.

PMID: 31037384 DOI: 10.1007/s00251-019-01115-y.


References
1.
Claesson L, Larhammar D, Rask L, Peterson P . cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure. Proc Natl Acad Sci U S A. 1983; 80(24):7395-9. PMC: 389957. DOI: 10.1073/pnas.80.24.7395. View

2.
Roche P, Cresswell P . Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature. 1990; 345(6276):615-8. DOI: 10.1038/345615a0. View

3.
Strubin M, MACH B, Long E . The complete sequence of the mRNA for the HLA-DR-associated invariant chain reveals a polypeptide with an unusual transmembrane polarity. EMBO J. 1984; 3(4):869-72. PMC: 557440. DOI: 10.1002/j.1460-2075.1984.tb01898.x. View

4.
Claesson-Welsh L, Barker P, Larhammar D, Rask L, Ruddle F, Peterson P . The gene encoding the human class II antigen-associated gamma chain is located on chromosome 5. Immunogenetics. 1984; 20(1):89-93. DOI: 10.1007/BF00373450. View

5.
Spiro R, Sairenji T, Humphreys R . Enhanced Ii expression after n-butyrate treatment of a P3HR-1 Burkitt's lymphoma subline which does not express HLA-D. Hematol Oncol. 1984; 2(3):239-47. DOI: 10.1002/hon.2900020303. View